Table 3. The 5-year disease-free survival (DFS) and 5-year overall survival (OS).
| Subtypes | n | 5-year DFS |
5-year OS |
||
|---|---|---|---|---|---|
| %±SE | P | %±SE | P | ||
| Total | 1521 | 80.3±1.0 | 87.0±0.9 | ||
| Luminal A | 946 | 83.7±1.2 | (ref.) | 90.4±1.0 | (ref.) |
| Luminal B | 170 | 73.5±3.4 | 0.005 | 76.1±3.4 | <0.001 |
| HER2 | 114 | 76.7±4.1 | 0.065 | 82.1±3.7 | 0.011 |
| Triple-negative | 291 | 74.4±2.6 | <0.001 | 84.0±2.2 | 0.003 |
| Lymph node positive | |||||
| Luminal A | 390 | 70.9±2.4 | (ref.) | 80.5±2.1 | (ref.) |
| Luminal B | 72 | 53.5±6.0 | 0.002 | 57.7±6.0 | <0.001 |
| HER2 | 47 | 53.9±7.7 | 0.022 | 60.3±7.6 | 0.003 |
| Triple-negative | 114 | 59.7±4.7 | 0.032 | 70.0±4.4 | 0.026 |
| Lymph node negative | |||||
| Luminal A | 543 | 92.6±1.1 | (ref.) | 97.1±0.7 | (ref.) |
| Luminal B | 97 | 88.3±3.3 | 0.257 | 89.2±3.2 | 0.002 |
| HER2 | 66 | 92.1±3.4 | 0.509 | 96.8±2.2 | 0.568 |
| Triple-negative | 172 | 84.7±2.8 | <0.001 | 93.3±1.9 | 0.015 |
*Follow-up date available; SE, standard error